187 related articles for article (PubMed ID: 29643476)
1. Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway.
Yu Y; Suryo Rahmanto Y; Lee MH; Wu PH; Phillip JM; Huang CH; Vitolo MI; Gaillard S; Martin SS; Wirtz D; Shih IM; Wang TL
Oncogene; 2018 Jul; 37(28):3778-3789. PubMed ID: 29643476
[TBL] [Abstract][Full Text] [Related]
2. Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer.
Yu Y; Suryo Rahmanto Y; Shen YA; Ardighieri L; Davidson B; Gaillard S; Ayhan A; Shi X; Xuan J; Wang TL; Shih IM
EBioMedicine; 2019 Sep; 47():184-194. PubMed ID: 31492560
[TBL] [Abstract][Full Text] [Related]
3. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules.
Yu Y; Gaillard S; Phillip JM; Huang TC; Pinto SM; Tessarollo NG; Zhang Z; Pandey A; Wirtz D; Ayhan A; Davidson B; Wang TL; Shih IeM
Cancer Cell; 2015 Jul; 28(1):82-96. PubMed ID: 26096845
[TBL] [Abstract][Full Text] [Related]
5. Reconstruction and signal propagation analysis of the Syk signaling network in breast cancer cells.
Naldi A; Larive RM; Czerwinska U; Urbach S; Montcourrier P; Roy C; Solassol J; Freiss G; Coopman PJ; Radulescu O
PLoS Comput Biol; 2017 Mar; 13(3):e1005432. PubMed ID: 28306714
[TBL] [Abstract][Full Text] [Related]
6. Full-length spleen tyrosine kinase inhibits the invasion and metastasis of human laryngeal squamous cell carcinoma.
Li Z; Cai Z; Tao B; Jin Q
Int J Clin Exp Pathol; 2015; 8(12):15786-93. PubMed ID: 26884848
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke-induced EGFR activation promotes epithelial mesenchymal migration of human retinal pigment epithelial cells through regulation of the FAK-mediated Syk/Src pathway.
Park GB; Kim D
Mol Med Rep; 2018 Mar; 17(3):3563-3574. PubMed ID: 29286114
[TBL] [Abstract][Full Text] [Related]
8. Mercury alters endogenous phosphorylation profiles of SYK in murine B cells.
Caruso JA; Carruthers N; Shin N; Gill R; Stemmer PM; Rosenspire A
BMC Immunol; 2017 Jul; 18(1):37. PubMed ID: 28716125
[TBL] [Abstract][Full Text] [Related]
9. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
10. Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells.
Zhang X; Shrikhande U; Alicie BM; Zhou Q; Geahlen RL
Mol Cancer Res; 2009 May; 7(5):634-44. PubMed ID: 19435818
[TBL] [Abstract][Full Text] [Related]
11. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
[TBL] [Abstract][Full Text] [Related]
12. ATM-Mediated Phosphorylation of Cortactin Involved in Actin Polymerization Promotes Breast Cancer Cells Migration and Invasion.
Lang L; Hou Y; Chen Y; Tu G; Tao J; Yang D; Xi L; Fu L; Sun K; Yin J; Chen R; Peng M; Liu S; Liu M
Cell Physiol Biochem; 2018; 51(6):2972-2988. PubMed ID: 30562756
[TBL] [Abstract][Full Text] [Related]
13. SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.
Moncayo G; Grzmil M; Smirnova T; Zmarz P; Huber RM; Hynx D; Kohler H; Wang Y; Hotz HR; Hynes NE; Keller G; Frank S; Merlo A; Hemmings BA
Neuro Oncol; 2018 Apr; 20(5):621-631. PubMed ID: 29401256
[TBL] [Abstract][Full Text] [Related]
14. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728
[TBL] [Abstract][Full Text] [Related]
15. Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration.
Hoellenriegel J; Coffey GP; Sinha U; Pandey A; Sivina M; Ferrajoli A; Ravandi F; Wierda WG; O'Brien S; Keating MJ; Burger JA
Leukemia; 2012 Jul; 26(7):1576-83. PubMed ID: 22362000
[TBL] [Abstract][Full Text] [Related]
16. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.
Luangdilok S; Box C; Patterson L; Court W; Harrington K; Pitkin L; Rhŷs-Evans P; O-charoenrat P; Eccles S
Cancer Res; 2007 Aug; 67(16):7907-16. PubMed ID: 17699797
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
[TBL] [Abstract][Full Text] [Related]
18. Syk-MyD88 Axis Is a Critical Determinant of Inflammatory-Response in Activated Macrophages.
Yi YS; Kim HG; Kim JH; Yang WS; Kim E; Jeong D; Park JG; Aziz N; Kim S; Parameswaran N; Cho JY
Front Immunol; 2021; 12():767366. PubMed ID: 35003083
[TBL] [Abstract][Full Text] [Related]
19. Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.
Benkisser-Petersen M; Buchner M; Dörffel A; Dühren-von-Minden M; Claus R; Kläsener K; Leberecht K; Burger M; Dierks C; Jumaa H; Malavasi F; Reth M; Veelken H; Duyster J; Zirlik K
PLoS One; 2016; 11(12):e0169159. PubMed ID: 28036404
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
